[Skip to Navigation]
Comment & Response
February 9, 2022

Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis

Author Affiliations
  • 1Uniformed Services University of the Health Sciences, Bethesda, Maryland
  • 2Division of Urology, Obstetrics and Gynecology, US Food and Drug Administration, Silver Spring, Maryland
JAMA Cardiol. 2022;7(4):463-464. doi:10.1001/jamacardio.2021.5857

To the Editor JAMA Cardiology recently initiated an ongoing discussion regarding the prevalence and significance of postvaccination myocarditis (PVM) in adolescents and the role that physicians and policy makers should play in communicating the risks of vaccination or nonvaccination to patients. We strongly agree with the position put forth by Navar et al1 that (1) the societal benefit of mass vaccination is overwhelming and (2) increased PVM reporting should be viewed as a reflection of increased surveillance and a working Vaccine Adverse Event Reporting System.

Add or change institution